NIIN Output Data
NIIN:
NSN:
Item Name:
INSULIN HUMAN INJECTION , USP
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC00002-8215-01 | 75602 | A | 3 | 2 | 6 | 54 | ||
HUMULIN-R | 75602 | A | 5 | 1 | 6 | 54 | ||
NDC00169-1833-11 | 60554 | A | 3 | 2 | 4 | ZZ | ||
HI-210 | 75602 | A | 3 | 2 | 4 | 54 | ||
NDC00002-8215-01 | 0A423 | A | 5 | 2 | 4 | ZZ |
CAGE Information
Code | Company |
---|---|
0A423 | CARDINAL HEALTH 100 INC DBA BINDLEY |
75602 | ELI LILLY AND COMPANY |
60554 | NOVO NORDISK INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
THPE | THERAPEUTIC EQUIVALENT | HUMULIN R BY LILLY |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 UNITS INSULIN PER ML. ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | INSULIN HUMAN INJECTION MODIFIED 100UN/ML VIAL |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
FEAT | SPECIAL FEATURES | MULTIPLE-DOSE VIAL; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA) |